AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Allorge, D Harlow, J Boulet, O Hayhurst, GP Chowdry, J Roth, E Crewe, K Lo-Guidice, JM Lhermitte, M Broly, F Tucker, GT Ellis, SW
Citation: D. Allorge et al., In-vitro analysis of the contribution of CYP2D6.35 to ultrarapid metabolism, PHARMACOGEN, 11(8), 2001, pp. 739-741

Authors: Prakash, PK Banerjee, M Harlow, J Hanna, FWF
Citation: Pk. Prakash et al., An unusual case of hypoglycaemia, DIABET MED, 18(9), 2001, pp. 769-770

Authors: Hayhurst, GP Harlow, J Chowdry, J Gross, E Hilton, E Lennard, MS Tucker, GT Ellis, SW
Citation: Gp. Hayhurst et al., Influence of phenylalanine-481 substitutions on the catalytic activity of cytochrome P450 2D6, BIOCHEM J, 355, 2001, pp. 373-379

Authors: Davidson, S Harlow, J
Citation: S. Davidson et J. Harlow, Guest editors' introduction: Benchmarking for design and test, IEEE DES T, 17(3), 2000, pp. 12-14

Authors: Ellis, SW Hayhurst, GP Lightfoot, T Smith, G Harlow, J Rowland-Yeo, K Larsson, C Mahling, J Lim, CK Wolf, CR Blackburn, MG Lennard, MS Tucker, GT
Citation: Sw. Ellis et al., Evidence that serine 304 is not a key ligand-binding residue in the activesite of cytochrome P450 2D6, BIOCHEM J, 345, 2000, pp. 565-571

Authors: Harlow, J
Citation: J. Harlow, Fuel economics, NEW SCI, 168(2269), 2000, pp. 55-55

Authors: Harlow, J Duell, D Steeg, DS Nenner, V
Citation: J. Harlow et al., Information dissemination and marketing in California, J NURS ADM, 29(4), 1999, pp. 6-8
Risultati: 1-7 |